Zentek (CVE:ZEN) Trading Up 41.8% - Time to Buy?

Key Points

• Zentek Ltd. shares surged by 41.8% on Wednesday, reaching a high of C$1.70 before settling at C$1.29.
• The company, focused on graphene research and development, has a market cap of C$135.08 million and noteworthy financial ratios, including a PE ratio of -16.13.
• Trading volume increased significantly, with over 407,000 shares traded, marking a 752% rise compared to its average session volume.

Zentek Ltd. (CVE:ZEN - Get Free Report)'s stock price shot up 41.8% during trading on Wednesday . The stock traded as high as C$1.70 and last traded at C$1.29. 407,343 shares changed hands during trading, an increase of 752% from the average session volume of 47,792 shares. The stock had previously closed at C$0.91.

Zentek Trading Up 0.9%

The stock has a market capitalization of C$122.51 million, a price-to-earnings ratio of -14.63 and a beta of 0.29. The company's 50 day moving average is C$1.20 and its 200 day moving average is C$1.57. The company has a debt-to-equity ratio of 4.97, a quick ratio of 7.59 and a current ratio of 2.06.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.